Amgen (AMGN) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Amgen (AMGN) over the last 16 years, with Q4 2024 value amounting to $5.6 billion.
- Amgen's Accumulated Depreciation & Amortization rose 3736.18% to $5.6 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $5.6 billion, marking a year-over-year increase of 3736.18%. This contributed to the annual value of $5.6 billion for FY2024, which is 3736.18% up from last year.
- Amgen's Accumulated Depreciation & Amortization amounted to $5.6 billion in Q4 2024, which was up 3736.18% from $4.1 billion recorded in Q4 2023.
- In the past 5 years, Amgen's Accumulated Depreciation & Amortization ranged from a high of $5.6 billion in Q4 2024 and a low of $841.0 million during Q1 2021
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $3.4 billion (2021), whereas its average is $2.9 billion.
- As far as peak fluctuations go, Amgen's Accumulated Depreciation & Amortization soared by 8343.37% in 2020, and later crashed by 624.3% in 2021.
- Quarter analysis of 5 years shows Amgen's Accumulated Depreciation & Amortization stood at $3.6 billion in 2020, then dropped by 5.64% to $3.4 billion in 2021, then increased by 0.56% to $3.4 billion in 2022, then grew by 19.14% to $4.1 billion in 2023, then surged by 37.36% to $5.6 billion in 2024.
- Its Accumulated Depreciation & Amortization stands at $5.6 billion for Q4 2024, versus $4.1 billion for Q4 2023 and $3.4 billion for Q4 2022.